Clinical impact of somatic alterations in prostate cancer patients with and without previously known germline BRCA1/2 mutations: Results from PROREPAIR-A study

被引：5

作者：

Lozano Mejorada, R. ^{[1
]}

Castro Marcos, E. ^{[2
,3
]}

Aragon, I. M. ^{[1
]}

Thorne, H. ^{[4
]}

Lopez Campos, F. ^{[5
]}

Sanz, A. ^{[1
]}

Alonso, C. ^{[6
]}

Anido, U. ^{[7
]}

Juan Fita, M. J. ^{[8
]}

Gutierrez Pecharroman, A. M. ^{[9
]}

Ramirez-Backhaus, M. ^{[10
]}

Balmana, J. ^{[11
]}

Chirivella Gonzalez, I. ^{[12
]}

Llort, G. ^{[13
,14
]}

Romero Laorden, N. ^{[15
]}

Arevalo Lobera, S. ^{[16
]}

Rubio Briones, J. ^{[10
]}

Pritchard, C. C. ^{[17
]}

Sandhu, S. ^{[4
]}

Olmos Hidalgo, D. ^{[1
]}

机构：

[1] Spanish Natl Canc Res Ctr CNIO, Prostate Canc Clin Res Unit, Madrid, Spain

[2] Hosp Univ Virgen de la Victoria, Med Oncol, Malaga, Spain

[3] Inst Invest Biomed Malaga, Malaga, Spain

[4] Peter MacCallum Canc Ctr, Med Oncol, Melbourne, Vic, Australia

[5] Hosp Univ Ramon y Cajal, Radiat Oncol Dept, Madrid, Spain

[6] Hosp Univ Princesa, Med Oncol Dept, Madrid, Spain

[7] CHUS Complejo Hosp Univ Santiago de Compostela SE, Med Oncol Dept, Santiago De Compostela, La Coruna, Spain

[8] Fdn Inst Valenciano Oncol, Med Oncol, Valencia, Spain

[9] Hosp Getafe, Pathol, Getafe, Spain

[10] Fdn Inst Valenciano Oncol, Urol Dept, Valencia, Spain

[11] Vall dHebron Univ Hosp, Dept Med Oncol, Hereditary Canc Genet Grp 4, VHIO, Barcelona, Spain

[12] Hosp Clin Univ Valencia, Med Oncol Dept, Valencia, Spain

[13] Corp Sanitaria Univ, Hereditary Canc Unit 8, Parc Tauli Sabadell, Barcelona, Spain

[14] Corp Sanitaria Univ, Barcelona, Spain

[15] Hosp Univ Princesa, Med Oncol Dept, Madrid, Spain

[16] Hosp Donostia, Med Oncol Dept, San Sebastian, Spain

[17] Univ Washington, Lab Med, Seattle, WA 98195 USA

来源：

ANNALS OF ONCOLOGY | 2020年 / 31卷

关键词：

D O I：

10.1016/j.annonc.2020.08.872

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

612MO

引用

页码：S509 / S510

页数：2